Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity

Clinical cases of allergic reaction that are due to excipients containing polyethylene glycol (PEG), a hydrophilic molecule commonly used in drug/vaccine formulations, has attracted much attention in recent years. In order to develop PEG-free adjuvants, we investigated the feasibility of natural ing...

Full description

Bibliographic Details
Main Authors: Chih-An Lin, Hui-Min Ho, Parthiban Venkatesan, Chiung-Yi Huang, Yu-Jhen Cheng, Yu-Hsing Lin, Hua-Yang Lin, Tzu-Yang Chen, Ming-Hsi Huang, Ping-Shan Lai
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/10/1569
_version_ 1797513388360728576
author Chih-An Lin
Hui-Min Ho
Parthiban Venkatesan
Chiung-Yi Huang
Yu-Jhen Cheng
Yu-Hsing Lin
Hua-Yang Lin
Tzu-Yang Chen
Ming-Hsi Huang
Ping-Shan Lai
author_facet Chih-An Lin
Hui-Min Ho
Parthiban Venkatesan
Chiung-Yi Huang
Yu-Jhen Cheng
Yu-Hsing Lin
Hua-Yang Lin
Tzu-Yang Chen
Ming-Hsi Huang
Ping-Shan Lai
author_sort Chih-An Lin
collection DOAJ
description Clinical cases of allergic reaction that are due to excipients containing polyethylene glycol (PEG), a hydrophilic molecule commonly used in drug/vaccine formulations, has attracted much attention in recent years. In order to develop PEG-free adjuvants, we investigated the feasibility of natural ingredients in the human body such as hyaluronic acid in the form of hyaluronic acid-glycine cholesterol (HACH) conjugate as an excipient for vaccine formulation. Interestingly, HACH grafted with ~13 wt.% cholesterol has good water dispersity and can serve as an emulsifier to stabilize the squalene/water interfaces, yielding a milky white and isotropic emulsion (SQ@HACH) after being passed through a high-shear microfluidizer. Our results show that SQ@HACH particles possessed a unimodal average hydrodynamic diameter of approximately 190 nm measured by dynamic light scattering and exhibited good stability upon storage at 4 °C and 37 °C for over 20 weeks. The results of immunogenicity using a mouse model with ovalbumin (OVA) as the antigen revealed that SQ@HACH significantly enhanced antigen-specific immune responses, including the polarization of IgG antibodies, the cytokine secretions of T cells, and enhancement of cytotoxic T lymphocyte (CTL) activation. Moreover, SQ@HACH revealed lower local inflammation and rapidly absorbing properties compared with AlPO<sub>4</sub> after intramuscular injection in vivo, indicating the potential functions of the HA-derived conjugate as an excipient in vaccine formulations for enhancement of T cell-mediated immunity.
first_indexed 2024-03-10T06:16:51Z
format Article
id doaj.art-0573a835337448b38ce60e67c722bcc0
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T06:16:51Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-0573a835337448b38ce60e67c722bcc02023-11-22T19:37:43ZengMDPI AGPharmaceutics1999-49232021-09-011310156910.3390/pharmaceutics13101569Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated ImmunityChih-An Lin0Hui-Min Ho1Parthiban Venkatesan2Chiung-Yi Huang3Yu-Jhen Cheng4Yu-Hsing Lin5Hua-Yang Lin6Tzu-Yang Chen7Ming-Hsi Huang8Ping-Shan Lai9Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung City 402204, TaiwanNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli City 350401, TaiwanDepartment of Chemistry, National Chung Hsing University, Taichung City 402204, TaiwanNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli City 350401, TaiwanNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli City 350401, TaiwanPreclinical Development Research Department, Holy Stone Healthcare Co., Ltd., Hsinchu 114066, TaiwanPreclinical Development Research Department, Holy Stone Healthcare Co., Ltd., Hsinchu 114066, TaiwanDepartment of Chemistry, National Chung Hsing University, Taichung City 402204, TaiwanPh.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung City 402204, TaiwanPh.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung City 402204, TaiwanClinical cases of allergic reaction that are due to excipients containing polyethylene glycol (PEG), a hydrophilic molecule commonly used in drug/vaccine formulations, has attracted much attention in recent years. In order to develop PEG-free adjuvants, we investigated the feasibility of natural ingredients in the human body such as hyaluronic acid in the form of hyaluronic acid-glycine cholesterol (HACH) conjugate as an excipient for vaccine formulation. Interestingly, HACH grafted with ~13 wt.% cholesterol has good water dispersity and can serve as an emulsifier to stabilize the squalene/water interfaces, yielding a milky white and isotropic emulsion (SQ@HACH) after being passed through a high-shear microfluidizer. Our results show that SQ@HACH particles possessed a unimodal average hydrodynamic diameter of approximately 190 nm measured by dynamic light scattering and exhibited good stability upon storage at 4 °C and 37 °C for over 20 weeks. The results of immunogenicity using a mouse model with ovalbumin (OVA) as the antigen revealed that SQ@HACH significantly enhanced antigen-specific immune responses, including the polarization of IgG antibodies, the cytokine secretions of T cells, and enhancement of cytotoxic T lymphocyte (CTL) activation. Moreover, SQ@HACH revealed lower local inflammation and rapidly absorbing properties compared with AlPO<sub>4</sub> after intramuscular injection in vivo, indicating the potential functions of the HA-derived conjugate as an excipient in vaccine formulations for enhancement of T cell-mediated immunity.https://www.mdpi.com/1999-4923/13/10/1569hyaluronic acidcholesterolsqualenenanoemulsionvaccine adjuvantsPEG-free formulation
spellingShingle Chih-An Lin
Hui-Min Ho
Parthiban Venkatesan
Chiung-Yi Huang
Yu-Jhen Cheng
Yu-Hsing Lin
Hua-Yang Lin
Tzu-Yang Chen
Ming-Hsi Huang
Ping-Shan Lai
Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity
Pharmaceutics
hyaluronic acid
cholesterol
squalene
nanoemulsion
vaccine adjuvants
PEG-free formulation
title Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity
title_full Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity
title_fullStr Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity
title_full_unstemmed Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity
title_short Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity
title_sort hyaluronic acid glycine cholesterol conjugate based nanoemulsion as a potent vaccine adjuvant for t cell mediated immunity
topic hyaluronic acid
cholesterol
squalene
nanoemulsion
vaccine adjuvants
PEG-free formulation
url https://www.mdpi.com/1999-4923/13/10/1569
work_keys_str_mv AT chihanlin hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT huiminho hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT parthibanvenkatesan hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT chiungyihuang hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT yujhencheng hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT yuhsinglin hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT huayanglin hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT tzuyangchen hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT minghsihuang hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity
AT pingshanlai hyaluronicacidglycinecholesterolconjugatebasednanoemulsionasapotentvaccineadjuvantfortcellmediatedimmunity